These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24083612)

  • 61. HBV polymerase-derived peptide exerts an anti-HIV-1 effect by inhibiting the acetylation of viral integrase.
    Kim H; Lee SY; Choi YM; Kim BJ
    Biochem Biophys Res Commun; 2018 Jun; 501(2):541-546. PubMed ID: 29752938
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors.
    Jung S; Knauer O; Donhauser N; Eichenmüller M; Helm M; Fleckenstein B; Reil H
    AIDS; 2005 Aug; 19(12):1267-72. PubMed ID: 16052081
    [TBL] [Abstract][Full Text] [Related]  

  • 63. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
    Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
    J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.
    Berzsenyi MD; Woollard DJ; McLean CA; Preiss S; Perreau VM; Beard MR; Scott Bowden D; Cowie BC; Li S; Mijch AM; Roberts SK
    J Hepatol; 2011 Sep; 55(3):536-544. PubMed ID: 21266183
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller.
    Chevigne A; Delhalle S; Counson M; Beaupain N; Rybicki A; Verschueren C; Staub T; Schmit JC; Seguin-Devaux C; Deroo S
    AIDS; 2016 Jan; 30(3):377-82. PubMed ID: 26760231
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potential utility of GB virus type C as a preventive vaccine for HIV-1.
    Bagasra O; Bagasra AU; Sheraz M; Pace DG
    Expert Rev Vaccines; 2012 Mar; 11(3):335-47. PubMed ID: 22380825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mother-to-child transmission of GB virus C in a cohort of women coinfected with GB virus C and HIV in Bangkok, Thailand.
    Bhanich Supapol W; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; McNicholl JM; Vanprapar N; Asavapiriyanont S; Shaffer N; Butera S
    J Infect Dis; 2009 Jul; 200(2):227-35. PubMed ID: 19508162
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
    Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
    J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.
    Jang S; Hyun S; Kim S; Lee S; Lee IS; Baba M; Lee Y; Yu J
    Angew Chem Int Ed Engl; 2014 Sep; 53(38):10086-9. PubMed ID: 25056130
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.
    Capobianchi MR; Lalle E; Martini F; Poccia F; D'Offizi G; Antonucci G; Abbate I; Dianzani F
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):3-8. PubMed ID: 16914092
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GB virus C infection in Indonesian HIV-positive patients.
    Anggorowati N; Yano Y; Subronto YW; Utsumi T; Heriyanto DS; Mulya DP; Rinonce HT; Widasari DI; Lusida MI; Soetjipto ; Hayashi Y
    Microbiol Immunol; 2013 Apr; 57(4):298-308. PubMed ID: 23590588
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Peptide and non-peptide HIV fusion inhibitors.
    Jiang S; Zhao Q; Debnath AK
    Curr Pharm Des; 2002; 8(8):563-80. PubMed ID: 11945159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Cloning, Sequence Analysis and Expression of Recombinant E2 Protein of GB Virus C Genotype 7].
    Yang X; Zhao Y; Feng Y; Xia X
    Bing Du Xue Bao; 2016 Sep; 32(5):545-50. PubMed ID: 30001575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment.
    Tsuji K; Wang R; Kobayakawa T; Owusu KB; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2021 Jan; 30():115923. PubMed ID: 33316719
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes.
    Aneja R; Grigoletto A; Nangarlia A; Rashad AA; Wrenn S; Jacobson JM; Pasut G; Chaiken I
    J Pept Sci; 2019 Apr; 25(4):e3155. PubMed ID: 30809901
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide.
    Gomara MJ; Perez Y; Gomez-Gutierrez P; Herrera C; Ziprin P; Martinez JP; Meyerhans A; Perez JJ; Haro I
    Sci Rep; 2020 Sep; 10(1):14430. PubMed ID: 32879375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Peptide-Based HIV Entry Inhibitors.
    Pu J; Wang Q; Jiang S
    Adv Exp Med Biol; 2022; 1366():15-26. PubMed ID: 35412132
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peptide Amphiphilic-Based Supramolecular Structures with Anti-HIV-1 Activity.
    Gómara MJ; Pons R; Herrera C; Ziprin P; Haro I
    Bioconjug Chem; 2021 Sep; 32(9):1999-2013. PubMed ID: 34254794
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human pegivirus (HPgV, GBV-C) RNA in volunteer blood donors from a public hemotherapy service in Northern Brazil.
    Silva ASN; Silva CP; Barata RR; da Silva PVR; Monteiro PDJ; Lamarão L; Burbano RMR; Nunes MRT; de Lima PDL
    Virol J; 2020 Oct; 17(1):153. PubMed ID: 33054824
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds.
    Gómara MJ; Galatola R; Gutiérrez A; Gimeno MC; Gatell JM; Sánchez-Merino V; Yuste E; Haro I
    Curr Med Chem; 2014; 21(2):238-50. PubMed ID: 24083612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.